Impact of oral vancomycin treatment duration on rate of Clostridioides difficile recurrence in patients requiring concurrent systemic antibiotics.
Diana KwiatkowskiKassandra MarshAlyson KatzJohn PapadopoulosJonathan SoVincent J MajorPhilip M SommerSarah HochmanYanina DubrovskayaSerena ArnoukPublished in: Infection control and hospital epidemiology (2024)
Oral vancomycin prescribing relative to the systemic antibiotic end date may affect CDI recurrence to a greater extent than total vancomycin duration alone. Further studies are needed to confirm these findings.